Fluid Overload Management In Peritoneal Dialysis Therapeutics
1. Extraneal patent expiration
Treatment: Peritoneal dialysis solution
EXTRANEAL IPR and PTAB Proceedings
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6077836 | VANTIVE US HLTHCARE | Peritoneal dialysis and compositions for use therein |
Jun, 2017
(8 years ago) | |
| US6248726 | VANTIVE US HLTHCARE | Method of peritoneal dialysis using glucose polymer solutions |
Jun, 2018
(7 years ago) | |
Drugs and Companies using ICODEXTRIN ingredient
Market Authorisation Date: 20 December, 2002
Dosage: SOLUTION
More Information on Dosage
EXTRANEAL family patents
